Stay updated on HY209 Gel Phase I Clinical Trial

Sign up to get notified when there's something new on the HY209 Gel Phase I Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HY209 Gel Phase I Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s study details page now shows an updated site revision number (v3.5.3 instead of v3.5.2) at the bottom of the page.
    Difference
    0.1%
    Check dated 2026-04-25T18:55:52.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T14:47:15.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0 and the previous v3.4.3 revision was removed.
    Difference
    0.1%
    Check dated 2026-03-19T23:39:07.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been applied, replacing v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:20:49.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.4.2, replacing the previous v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:15:34.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Only a site revision update from v3.4.0 to v3.4.1 is visible, with no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:55:35.000Z thumbnail image

Stay in the know with updates to HY209 Gel Phase I Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HY209 Gel Phase I Clinical Trial page.